Published in

American Medical Association, JAMA Cardiology, 2(5), p. 209, 2020

DOI: 10.1001/jamacardio.2019.4759

Links

Tools

Export citation

Search in Google Scholar

Eligibility and Preventive Potential for New Evidence-Based Cardiovascular Drugs in Secondary Prevention

Journal article published in 2020 by Martin Bødtker Mortensen ORCID, Michael Joseph Blaha, Børge Grønne Nordestgaard
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO